Caitong International Asset Management Co., LTD Bristol Myers Squibb CO Transaction History
Caitong International Asset Management Co., LTD
- $140 Billion
- Q2 2025
A detailed history of Caitong International Asset Management Co., LTD transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Caitong International Asset Management Co., LTD holds 6,060 shares of BMY stock, worth $278,457. This represents 0.2% of its overall portfolio holdings.
Number of Shares
6,060
Previous 33
18263.64%
Holding current value
$278,457
Previous $2.01 Million
13835.27%
% of portfolio
0.2%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding BMY
# of Institutions
2,677Shares Held
1.58BCall Options Held
25.9MPut Options Held
24.1M-
Vanguard Group Inc Valley Forge, PA191MShares$8.79 Billion0.22% of portfolio
-
Black Rock Inc. New York, NY159MShares$7.29 Billion0.15% of portfolio
-
Jpmorgan Chase & CO New York, NY108MShares$4.97 Billion0.52% of portfolio
-
State Street Corp Boston, MA94.8MShares$4.36 Billion0.24% of portfolio
-
Capital International Investors Los Angeles, CA66.5MShares$3.05 Billion0.83% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $97.7B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...